PortfoliosLab logoPortfoliosLab logo
HSY vs. UTHR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HSY vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Hershey Company (HSY) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HSY achieves a 1.25% return, which is significantly lower than UTHR's 12.05% return. Over the past 10 years, HSY has underperformed UTHR with an annualized return of 9.11%, while UTHR has yielded a comparatively higher 17.67% annualized return.


HSY

1D
0.45%
1M
-6.45%
YTD
1.25%
6M
1.34%
1Y
8.70%
3Y*
-8.39%
5Y*
3.29%
10Y*
9.11%

UTHR

1D
0.10%
1M
-5.79%
YTD
12.05%
6M
10.52%
1Y
90.80%
3Y*
33.49%
5Y*
24.97%
10Y*
17.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HSY vs. UTHR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HSY
The Hershey Company
1.25%10.98%-6.51%-17.88%21.86%29.58%5.90%40.20%-2.92%12.33%
UTHR
United Therapeutics Corporation
12.05%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%

Correlation

The correlation between HSY and UTHR is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jun 17, 1999

0.15

Fundamentals

Market Cap

HSY:

$37.11B

UTHR:

$25.77B

EPS

HSY:

$5.38

UTHR:

$27.00

PE Ratio

HSY:

33.80

UTHR:

20.22

PS Ratio

HSY:

3.08

UTHR:

8.21

PB Ratio

HSY:

7.84

UTHR:

4.37

Total Revenue (TTM)

HSY:

$11.99B

UTHR:

$3.17B

Gross Profit (TTM)

HSY:

$4.17B

UTHR:

$2.74B

EBITDA (TTM)

HSY:

$2.04B

UTHR:

$1.75B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HSY vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HSY
HSY Risk / Return Rank: 5050
Overall Rank
HSY Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
HSY Sortino Ratio Rank: 4848
Sortino Ratio Rank
HSY Omega Ratio Rank: 4646
Omega Ratio Rank
HSY Calmar Ratio Rank: 5151
Calmar Ratio Rank
HSY Martin Ratio Rank: 5252
Martin Ratio Rank

UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HSY vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Hershey Company (HSY) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HSYUTHRDifference
Sharpe ratioReturn per unit of total volatility

-1.61

Sortino ratioReturn per unit of downside risk

-3.57

Omega ratioGain probability vs. loss probability

1.08

1.49

-0.41

Calmar ratioReturn relative to maximum drawdown

0.35

8.58

-8.23

Martin ratioReturn relative to average drawdown

0.87

20.13

-19.25

HSY vs. UTHR - Sharpe Ratio Comparison

The current HSY Sharpe Ratio is 0.32, which is lower than the UTHR Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of HSY and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HSY vs. UTHR - Drawdown Comparison

The maximum HSY drawdown since its inception was -49.15%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for HSY and UTHR.


Loading charts...

Drawdown Indicators


HSYUTHRDifference

Max Drawdown

Largest peak-to-trough decline

-49.15%

-93.18%

+44.03%

Max Drawdown (1Y)

Largest decline over 1 year

-25.01%

-10.64%

-14.37%

Max Drawdown (3Y)

Largest decline over 3 years

-42.23%

-33.00%

-9.23%

Max Drawdown (5Y)

Largest decline over 5 years

-45.25%

-33.00%

-12.25%

Max Drawdown (10Y)

Largest decline over 10 years

-45.25%

-55.56%

+10.31%

Current Drawdown

Current decline from peak

-28.02%

-8.51%

-19.51%

Average Drawdown

Average peak-to-trough decline

-13.10%

-35.31%

+22.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.00%

4.53%

+5.47%

Volatility

HSY vs. UTHR - Volatility Comparison

The Hershey Company (HSY) has a higher volatility of 9.48% compared to United Therapeutics Corporation (UTHR) at 5.01%. This indicates that HSY's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HSYUTHRDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.48%

5.01%

+4.47%

Volatility (6M)

Calculated over the trailing 6-month period

20.08%

25.94%

-5.86%

Volatility (1Y)

Calculated over the trailing 1-year period

27.49%

47.55%

-20.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.77%

35.08%

-12.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.44%

35.06%

-11.62%

Dividends

HSY vs. UTHR - Dividend Comparison

HSY's dividend yield for the trailing twelve months is around 3.11%, while UTHR has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
HSY
The Hershey Company
3.11%3.01%3.24%2.39%1.67%1.76%2.07%2.03%2.57%2.24%2.32%2.50%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

HSY vs. UTHR - Financials Comparison

This section allows you to compare key financial metrics between The Hershey Company and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B2.50B3.00B20222023202420252026
3.10B
781.50M
(HSY) Total Revenue
(UTHR) Total Revenue
Values in USD except per share items

HSY vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between The Hershey Company and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
39.4%
82.9%
Portfolio components
HSY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Hershey Company reported a gross profit of 1.22B and revenue of 3.10B. Therefore, the gross margin over that period was 39.4%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

HSY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Hershey Company reported an operating income of 640.69M and revenue of 3.10B, resulting in an operating margin of 20.6%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

HSY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Hershey Company reported a net income of 435.11M and revenue of 3.10B, resulting in a net margin of 14.0%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.


Frequently Asked Questions


HSY and UTHR have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HSY has higher volatility (9.48%) compared to UTHR (5.01%). In terms of maximum drawdown, HSY dropped -49.15% vs UTHR's -93.18%.

UTHR currently has the higher Sharpe Ratio (1.92 vs 0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HSY and UTHR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer